GME
59
3
DOW
36
2
R
70
7
DFS
62
3
CA
38
9
MA
65
-2
V
70
-2
BBY
56
4
IFF
59
-3
MTB
55
5
ES
41
-2
IPG
53
3
PYPL
31
6
FE
53
-2
CHD
50
-6
MAC
44
-2
GLW
52
3
JBHT
50
5
PRGO
37
-3
TSN
44
-2
GME
59
3
DOW
36
2
R
70
7
DFS
62
3
CA
38
9
MA
65
-2
V
70
-2
BBY
56
4
IFF
59
-3
MTB
55
5
ES
41
-2
IPG
53
3
PYPL
31
6
FE
53
-2
CHD
50
-6
MAC
44
-2
GLW
52
3
JBHT
50
5
PRGO
37
-3
TSN
44
-2
Financhill
Back

Midland States Bancorp Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
22

MSBI
Midland States Bancorp

Last Price:
$19.39
Seasonality Move:
-1.11%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.00
Seasonality Move:
1.75%
Sell
22
Midland States Bancorp (MSBI) is a Sell

Is Midland States Bancorp a Buy, Sell or Hold?

  • The current Midland States Bancorp [MSBI] share price is $19.33. The Score for MSBI is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • MSBI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MSBI Stock Price Chart

What is Midland States Bancorp's stock price today?

  • The Midland States Bancorp share price today is $19.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSBI is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

MSBI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -28685 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.98 - 23.48) Sell
Bollinger Bands (100): (21.31 - 26.33) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

MSBI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.67 Sell
20-day SMA: 20.62 Sell
50-day SMA: 23.25 Sell
200-day SMA: 23.27 Sell
8-day EMA: 19.68 Sell
20-day EMA: 20.57 Sell
50-day EMA: 22.31 Sell
200-day EMA: 23.4 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Midland States Bancorp Earnings Growth & MSBI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.38 per share, and an increase next year of $0.21 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Midland States Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):